6 Sep 2018
AMF publishes results of Givaudan’s second tender offer for the remaining shares of Naturex
Following the closure of the second tender offer period initiated by Givaudan for the remaining outstanding shares of Naturex, the Autorité des marchés financiers (AMF) has now published the results.
31 Aug 2018
Givaudan receives strong investment grade credit ratings
Givaudan announces that it has received an A- credit rating, with a stable outlook, from S&P Global Ratings (“S&P”) and a Baa1 rating, with stable outlook, from Moody’s Investors Service (“Moody’s”).
30 Aug 2018
2018 Half year conference
Givaudan’s business prospects in the promising markets of the South East Asia region was the focus of the Company’s 18th traditional half year conference for investor analysts, held on 30 August in Zurich. Over 60 participants attended to hear of the Company’s current business activities and plans to capitalise on the region’s potential.
29 Aug 2018
Givaudan Fragrances announces strategic partnership with Synthite
Givaudan is excited to announce the formation of a strategic partnership with Synthite for the development of exclusive innovative natural ingredients for its Fragrance business.
7 Aug 2018
Reopening of Givaudan’s tender offer for the remaining shares of Naturex on 8 August 2018
Givaudan now holds 9,358,019 of Naturex shares, representing 97.24% of the capital, based on the total number of shares as of 31 July 2018. The tender offer will now re-open from 8 August 2018 until 3 September 2018 inclusive, under the same terms.
19 Jul 2018
2018 Half year results
Givaudan Group sales for the first six months of the year were CHF 2,674 million, an increase of 5.6% on a like-for-like basis and 7.7% in Swiss francs.
27 Jun 2018
Opening of the tender offer in cash for the remaining outstanding shares of Naturex on 28 June
Givaudan today announced the tender offer in cash for all remaining outstanding shares of Naturex will open on 28 June, following clearance of the offer by the French markets regulator Autorité des marchés financiers (AMF).
7 Jun 2018
Givaudan files draft tender offer in cash for the shares of the company Naturex
On 7 June 2018, Givaudan announced that it filed a draft tender offer in cash for the shares of the Company Naturex with the AMF (Autorités des Marchés Financiers).
5 Jun 2018
Givaudan completes acquisition of 40.5% of the shares in Naturex and confirms intention to launch cash tender offer for the remaining outstanding shares
Givaudan today announces it has successfully completed the acquisition of 40.5% of the shares of Naturex, a French public listed company, for EUR 135 per share and a total consideration of EUR 522 million.
4 Jun 2018
Givaudan completes the acquisition of Expressions Parfumées
Givaudan, the global leader in flavours and fragrances, today announced it has completed the acquisition of Expressions Parfumées, a French fragrance creation house, from its current shareholders, Orfite and Expressions Parfumées’ management.
14 May 2018
Givaudan completes acquisition of Nutrition Division of Centroflora
Givaudan, the global leader in fragrances and flavours, today announced it has completed the acquisition of the Nutrition Division of Centroflora Group (Centroflora Nutra), a world player in natural extracts.
16 Apr 2018
Givaudan Active Beauty to launch Vetivyne™, a new cosmetic active offering powerful beauty benefits
Givaudan Active Beauty combined the world of fragrances and cosmetics to create Vetivyne™, a new patent-pending powerful active ingredient with both anti-ageing benefits and long lasting properties to enhance fragrance wear.
11 Apr 2018
2018 annual investor conference
This year’s annual investor conference, held in Vernier (Geneva) on 10 April 2018, assembled 39 investors and analysts from institutions in Europe.
10 Apr 2018
2018 First quarter sales
In the first three months of 2018 Givaudan recorded sales of CHF 1,308 million, an increase of 5.0% on a like-for-like basis, and 5.4% in Swiss francs compared to the previous year.
28 Mar 2018
Givaudan announces changes to the Executive Committee
Givaudan announced today that Chris Thoen, Head of Global Science & Technology, decided for private reasons to retire at the end of August 2018. Currently an EC-member, he will step down from the Executive Committee at the end of May and continue to provide advice on strategic projects until his retirement.